A detailed history of Addison Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Addison Advisors LLC holds 10,570 shares of PFE stock, worth $313,506. This represents 0.1% of its overall portfolio holdings.

Number of Shares
10,570
Previous 8,578 23.22%
Holding current value
$313,506
Previous $238,000 23.95%
% of portfolio
0.1%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $50,317 - $58,963
1,992 Added 23.22%
10,570 $295,000
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $19,262 - $22,119
-744 Reduced 7.98%
8,578 $238,000
Q4 2023

Feb 02, 2024

BUY
$26.13 - $33.94 $25,346 - $32,921
970 Added 11.61%
9,322 $268,000
Q3 2023

Nov 07, 2023

BUY
$32.09 - $37.51 $25,768 - $30,120
803 Added 10.64%
8,352 $277,000
Q2 2023

Aug 03, 2023

SELL
$36.12 - $41.79 $15,025 - $17,384
-416 Reduced 5.22%
7,549 $276,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $945 - $1,230
24 Added 0.3%
7,965 $324,000
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $69,179 - $90,306
-1,657 Reduced 17.26%
7,941 $407,000
Q3 2022

Oct 28, 2022

SELL
$43.76 - $53.42 $4,769 - $5,822
-109 Reduced 1.12%
9,598 $420,000
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $15,075 - $17,875
324 Added 3.45%
9,707 $509,000
Q1 2022

Apr 29, 2022

BUY
$45.75 - $56.69 $68,899 - $85,375
1,506 Added 19.12%
9,383 $486,000
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $151,809 - $225,032
3,674 Added 87.41%
7,877 $465,000
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $1,491 - $1,915
38 Added 0.91%
4,203 $181,000
Q2 2021

Jul 29, 2021

SELL
$35.91 - $40.68 $3,590 - $4,068
-100 Reduced 2.34%
4,165 $163,000
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $142,749 - $181,518
4,265 New
4,265 $157,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.